Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

7.98
Delayed Data
As of 4:00pm ET
 +0.20 / +2.57%
Today’s Change
2.02
Today|||52-Week Range
9.51
+117.44%
Year-to-Date

Today’s Trading

Previous close7.78
Today’s open7.76
Day’s range7.17 - 8.05
Volume3,734,229
Average volume (3 months)2,492,762
Market cap$857.8M
Dividend yield--
Data as of 4:00pm ET, 08/17/2017

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)-73.12%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-42.81%
P/E ratioNM
Price/Sales68.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
--Quidel Corp-0.16-0.58%
ALRPRBAlere Inc-1.81-0.46%
QDELQuidel Corp-0.37-1.13%
LNTHLantheus Holdings In...+0.40+2.55%
Data as of 4:00pm ET, 08/17/2017

Financials

Next reporting dateAugust 24, 2017
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$3.2M
Annual profit (last year)-$59.0M
Net profit margin-1,825.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
Chief Financial Officer &
Vice President
Michael R. Garone
Corporate headquarters
Morris Plains, New Jersey

Forecasts